DB18404InvestigationalGene Therapies
Cotsiranib: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Prostaglandin G/H synthase 2 and Transforming growth factor beta-1 proprotein
- Also known as
- STP705 (small interfering RNA (siRNA) therapeutic directed against transforming growth factor-beta 1 (TGF-beta 1) and cyclo-oxygenase-2 (COX-2))
- Code names
- STP-705
Resolves to
Compound
Targets
What you can answer from here — as of October 05, 2026
Which drugs share a target with Cotsiranib, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account